Perspective on hormone therapy 10 years after the WHI

Maturitas

Volumn 76, Issue 3, 2013, Pages 208-212

  Ghazal, Sanaz ^a   Pal, Lubna ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Estrogen; HRT; Menopause; MHT; Progestin; WHI

Indexed keywords

ALPHA TOCOPHEROL; CLONIDINE; ESTROGEN; GABAPENTIN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PHYTOESTROGEN; PROGESTERONE;

ACTAEA RACEMOSA; BREAST CANCER; CANCER RISK; ENDOMETRIUM CANCER; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; POSTMENOPAUSE; REVIEW; TREATMENT DURATION; WOMEN'S HEALTH;

ESTROGEN; HRT; MENOPAUSE; MHT; PROGESTIN; WHI;

BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MENOPAUSE; WOMEN'S HEALTH;

EID: 84887437849     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2013.08.014     Document Type: Review

References (52)

1. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
2. G.L. Anderson, M. Limacher, A.R. Assaf Women's Health Initiative Steering Committee Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial JAMA 291 2004 1701 1712
3. M.J. Stampfer, and G.A. Colditz Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence Prev Med 20 1991 47 63
4. B.E. Henderson, A. Paganini-Hill, and R.K. Ross Decreased mortality in users of estrogen replacement therapy Arch Intern Med 151 1991 75 78
5. D. Grady, S.M. Rubin, and D.B. Petitti Hormone therapy to prevent disease and prolong life in postmenopausal women Ann Intern Med 117 1992 1016 1037
6. E. Barrett-Connor, and D. Grady Hormone replacement therapy, heart disease, and other considerations Annu Rev Public Health 19 1998 55 72
7. Guidelines for counseling postmenopausal women about preventative hormone therapy. American College of Physicians Ann Intern Med 117 1992 1038 1041
8. N.L. Keating, P.D. Cleary, A.S. Rossi, A.M. Zaslavsky, and J.Z. Ayanian Use of hormone replacement therapy by postmenopausal women in the United States Ann Intern Med 130 1999 545 553
9. J.S. Haas, C.P. Kaplan, E.P. Gerstenberger, and K. Kerlikowske Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results Ann Intern Med 140 2004 184 188
10. Y. Du, M. Dören, H.U. Melchert, C. Scheidt-Nave, and H. Knopf Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003 BMC Womens Health 7 October 2007 19
11. Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: Recommendations and rationale Ann Intern Med 137 2002 834 839
12. C.L. Roumie, E.L. Grogan, and W. Falbe A three-part intervention to change the use of hormone replacement therapy in response to new evidence Ann Intern Med 141 2004 118
13. A.L. Hersh, M.L. Stefanick, and R.S. Stafford National use of postmenopausal hormone therapy: annual trends and response to recent evidence JAMA 292 2004 47
14. S.R. Majmudar, E.A. Almasi, and R.S. Stafford Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative JAMA 292 2004 1983
15. J. Hsia, D. Langer, and J.E. Manson Conjugated equine estrogens and the risk of coronary heart disease Arch Intern Med 166 2006 357 365
16. J.E. Rossouw, R.L. Prentice, and J.E. Manson Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause JAMA 297 2007 1465 1477
17. North American Menopause Society The 2012 hormone therapy position statement of The North American Menopause Society Menopause 19 3 2012 257 271
18. C.A. Stuenkel, M.L.S. Gass, and J.E. Manson A decade after the women's health initiative - the experts do agree Menopause 19 8 2012 1 2
19. K. Schenck-Gustafsson, M. Brincat, and C.T. Erel EMASEMAS position statement: managing the menopause in the context of coronary heart disease Maturitas 68 January (1) 2011 94 97
20. G.A. Bachmann Vasomotor flushes in menopausal women Am J Obstet Gynecol 180 Suppl. 1999 S312 S316
21. E.A. Daly, A. Gray, D. Barlow, K. McPherson, M. Roche, and M. Vessey Measuring the impact of menopausal symptoms on quality of life BMJ 307 1993 836 840
22. V.M. Barnabei, B.B. Cochrane, A.K. Aragaki for the Women's Health Initiative Investigators Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative Obstet Gynecol 105 2005 1063 1073
23. National Institutes of Health, and State-of-the-Science Panel National Institutes of Health State-of-the-Science Conference statement: Management of menopause-related symptoms Ann Intern Med 142 2005 1003 1013
24. A. Maclennan, J. Broadbent, S. Lester, and V. Moore Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes Cochrane Database Sys Rev 4 2004 CD002978
25. M. Canonico, G. Plu-Bureau, G.D. Lowe, and P.Y. Scarabin Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis BMJ 36 2008 1227 2123
26. W.H. Utian, D. Shoupe, G. Bachmann, J.V. Pinkerton, and J.H. Pickar Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate Fertil Steril 75 2001 1065 1079
27. S. Furness, H. Roberts, and J. Marjoribanks Hormone therapy in postmenopausal women and risk of endometrial hyperplasia Cochrane Database Syst Rev 2 2009 CD000402
28. A. Gadducci, N. Biglia, S. Cosio, P. Sismondi, and A.R. Genazzani Progestogen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue Gynecol Endocrinol 25 December (12) 2009 807 815 [Review]
29. A. Gompel Micronized progesterone and its impact on the endometrium and breast vs. progestogens Climacteric 15 Suppl. 1 2012 18 25
30. M. L'hermite HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT Climacteric 16 Suppl. 1 2013 44 53
31. N.V. Goletiani, D.R. Keith, and S.J. Gorsky Progesterone: review of safety for clinical studies Exp Clin Psychopharmacol. 15 October (5) 2007 427 444
32. L. Udoff, P. Langenberg, and E.Y. Adashi Combined continuous hormone replacement therapy: a critical review Obstet Gynecol 86 1995 306
33. E.A. Lindenfeld, and R.D. Langer Bleeding patterns of the hormone replacement therapies in the postmenopausal estrogen and progestin intervention trial Obstet Gynecol 100 2002 853
34. F. Laliberte, K. Dea, M.S. Dub, K.H. Kahler, M. Rolli, and P. Lefebvre Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy Menopause 17 2011 1052 1059
35. C. Straczek, E. Oger, M.B. Yon de Jonage-Canonico Estrogen and Thromboembolism Risk (ESTHER) Study Group Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration Circulation 112 2005 3495 3500
36. C. Renoux, S. Dell'aniello, E. Garbe, and S. Suissa Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study BMJ. 340 June 2010 c2519
37. American College of Obstetricians and Gynecologists ACOG committee opinion no. 556: Postmenopausal estrogen therapy: route of administration and risk of venous thromboembolism Obstet Gynecol 121 4 2013 887 890
38. F. Tremollieres, M. Brincat, C.T. Erel European Menopause and Andropause Society EMAS position statement: Managing menopausal women with a personal or family history of VTE Maturitas 69 2 2011 195 198
39. The North American Menopause Society The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society Menopause 14 2007 357 369
40. S. Elkinson, and L.P. Yang Ospemifene: first global approval Drugs 73 6 2013 605 612
41. K. Gemzell-Danielsson, P. Inki, and O. Heikinheimo Recent developments in the clinical use of the levonorgestrel-releasing intrauterine system Acta Obstet Gynecol Scandinavica 90 2011 1177 1188
42. E. Lundström, G. Söderqvist, and G. Svane Digitized assessment of mammographic breast density in patients who received low-dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate: a pilot study Fertil Steril 85 4 2006 989 995
43. R. Kagan The tissue selective estrogen complex: a novel approach to the treatment of menopausal symptoms J Womens Health 21 2012 975 981
44. J.V. Pinkerton, B.S. Komm, and S. Mirkin Tissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model Climacteric 2013 June [Epub ahead of print]
45. P. Villaseca Non-estrogen conventional and phytochemical treatments for vasomotor symptoms: what needs to be known for practice Climacteric 15 2 2012 115 124
46. M.K. Whiteman, C.A. Staropoli, P.W. Langenberg, R.J. McCarter, K.H. Kjerulff, and J.A. Flaws Smoking, body mass, and hot flashes in midlife women Obstet Gynecol 101 2003 264 272
47. N.E. Avis, C. Legault, and R.R. Coeytaux A randomized, controlled pilot study of acupuncture treatment for menopausal hot flashes Menopause 15 2008 1070 1078
48. E.E. Krebs, K.E. Ensrud, R. MacDonald, and T.J. Wilt Phytoestrogens for treatment of menopausal symptoms: a systematic review Obstet Gynecol 104 2004 824 836
49. C.I. Loprinzi, J.W. Kugler, and J.A. Sloan Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial Lancet 356 2000 2059 2063
50. T. Guttuso Jr., R. Kurlan, M.P. McDermott, and K. Kieburtz Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial Obstet Gynecol 101 2003 337 345
51. P. van Gastel, J.W. Kallewaard, M. van der Zanden, and H. de Boer Stellate-ganglion block as a treatment for severe postmenopausal flushing Climacteric 16 1 2013 41 47
52. R.L. Prentice, R. Langer, M.L. Stefanick for Women's Health Initiative Investigators Combined postmenopausal hormone therapy and cardiovascular disease: Toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial Am J Epidemiol 162 2005 404 414